Enzyme-Empowered "Two Birds with One Stone" Strategy for Amplifying Tumor Apoptosis and Metabolic Clearance

Hanyue Li1, Yihui Li2, Lina Su3

  • 1State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300192, P. R. China.

Insights

This study introduces Re@ReP-G, a nanomedicine that enhances cancer apoptosis by depleting tumor energy (ATP) and increasing hydrogen peroxide. This dual action also promotes safe metabolic clearance of the nanomedicine.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Nanomedicine faces challenges in cancer treatment due to tumor defense mechanisms fueled by adenosine triphosphate (ATP).
  • Tumor defenses include DNA repair, resistance to programmed cell death (apoptosis), and immune evasion, all relying on ATP.
  • Overcoming these ATP-dependent defenses is crucial for improving nanomedicine efficacy.

Purpose of the Study:

  • To develop a novel nanomedicine strategy to amplify enzyme-mediated tumor apoptosis and promote metabolic clearance.
  • To create a dual-action approach targeting both tumor energy supply and nanomedicine clearance.
  • To utilize glucose oxidase (GOx) and functionalized rhenium nanoclusters for enhanced cancer therapy.

Main Methods:

  • A novel nanomedicine, GOx-functionalized rhenium nanoclusters-doped polypyrrole (Re@ReP-G), was synthesized.
  • Re@ReP-G was designed to reduce ATP production and increase hydrogen peroxide (H2O2) via GOx enzymatic activity.
  • Laser-induced hyperthermia was employed to further enhance tumor apoptosis.

Main Results:

  • Re@ReP-G effectively reduced ATP production and increased H2O2 in the tumor microenvironment.
  • This led to downregulation of protective proteins (HSP70, HSP90, Bcl-2) and upregulation of pro-apoptotic protein Bax.
  • Cytochrome c release and severe tumor apoptosis were observed, alongside accelerated in vivo metabolic clearance of the nanomedicine.

Conclusions:

  • The Re@ReP-G nanomedicine offers a "two birds with one stone" strategy for cancer therapy.
  • It amplifies tumor apoptosis by disrupting energy metabolism and inducing cell death pathways.
  • The strategy also ensures safe and efficient metabolic clearance of the nanomedicine in vivo.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K